Gulmez Duygu Demiriz, Yilmaz Elvan Tekir, Karamustafa Meltem, Akkaya Ismail Olgun, Tekin Pinar
Department of Anesthesiology and Reanimation, Giresun University Faculty of Medicine, Giresun, Turkiye.
Department of Anesthesiology and Reanimation, Prof. Dr. A. Ilhan Ozdemir Training and Research Hospital, Giresun, Turkiye.
North Clin Istanb. 2020 Nov 24;9(3):275-278. doi: 10.14744/nci.2020.86094. eCollection 2022.
The new coronavirus disease, in which 100,000 of people are infected in the world, appears in tables ranging from asymptomatic course to severe acute respiratory distress syndrome. Extracorporeal membrane oxygenation (ECMO) is one of the salvage treatments applied in intubated patients due to high mortality. However, since ECMO treatment is a complicated treatment, the gain loss rate should be determined well. We aimed to share two cases that we applied ECMO treatment in our clinic. Although we could not achieve a successful result, we believe that new experiences should be shared in order to better understand the place of ECMO in coronavirus disease 2019 treatment.
新型冠状病毒病在全球已导致10万人感染，其临床表现多样，从无症状感染到严重急性呼吸窘迫综合征不等。体外膜肺氧合（ECMO）是用于插管患者的挽救治疗方法之一，因其死亡率高。然而，由于ECMO治疗是一种复杂的治疗方法，应妥善确定其得失率。我们旨在分享我们诊所应用ECMO治疗的两个病例。虽然我们没有取得成功的结果，但我们认为应该分享新的经验，以便更好地了解ECMO在2019冠状病毒病治疗中的地位。
